USPTO 2015–2025 USPTO PatentsView US Corporation

THERAGUN, INC.

USPTO PatentsView assignee record — 65 granted patents across 12 technology areas, active 2019–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI).

65
Total patents granted
12
CPC technology areas
5.0
Avg claims per patent
+233%
5-year filing velocity

Portfolio overview

THERAGUN, INC. has been granted 65 US utility patents between 2019 and 2022, placing THERAGUN, INC. at rank #5,328 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 5.0 claims per patent with primary concentration in A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI). As a US Corporation, THERAGUN, INC. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 29.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 50 grants, compared with 15 in the 2015–2019 window — a +233% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. THERAGUN, INC.'s 5.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark THERAGUN, INC. against peers pursuing similar technology classes.

How does THERAGUN compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows THERAGUN holds 65 patents — placing it at rank #5,328 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2019–2022

0102030 2019202020212022 2
USPTO utility patent grants by year · 2019–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
THERAGUN, INC. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 15 23.1%
2020 25 38.5%
2021 23 35.4%
2022 2 3.1%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Simple
Velocity Accelerating

Where it ranks

Overall rank by patents

#5,328

Across all tracked assignees

Innovation Score

29.9 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does THERAGUN, INC. hold?
THERAGUN, INC. holds 65 US granted patents filed between 2019 and 2022, spanning 12 technology areas.
What is THERAGUN, INC.'s Innovation Score?
THERAGUN, INC. has an Innovation Score of 29.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does THERAGUN, INC. focus on?
THERAGUN, INC.'s top technology area is A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY) with 20 patents. The company has filed patents in 12 CPC subclasses total.
Is THERAGUN, INC.'s patent filing rate increasing or decreasing?
THERAGUN, INC.'s recent filing velocity is +233% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for THERAGUN, INC.'s patents?
THERAGUN, INC.'s patents average 5.0 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the THERAGUN, INC. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope